People · Operator
Named in public records as an officer, director or promoter · active 2017–2017 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cydan II, Inc. | — | Biotechnology | Series A | $10.7M | $385.6M | 2017 |
Barbara M. Dalton at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Barbara M. Dalton on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mette Kirstine Agger | 1 | 6 |
| Christoph M. Adams | 1 | 4 |
| David M. Mott | 1 | 4 |
| James M. McArthur | 1 | 2 |
| Sara M. Nayeem | 1 | 2 |
| Sandip Kirstine Agarwala | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.